CT45A10
gene geneOn this page
Summary
CT45A10 (cancer/testis antigen family 45 member A10, HGNC:51263) is a protein-coding gene on chromosome Xq26.3, encoding Cancer/testis antigen family 45 member A10 (P0DMU9).
Enables identical protein binding activity. Located in nucleus.
Source: NCBI Gene 102723631 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 1 total
- MANE Select transcript:
NM_001291529
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:51263 |
| Approved symbol | CT45A10 |
| Name | cancer/testis antigen family 45 member A10 |
| Location | Xq26.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000269586 |
| Ensembl biotype | protein_coding |
| Entrez | 102723631 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 5 protein_coding
ENST00000611668, ENST00000617981, ENST00000682849, ENST00000865154, ENST00000922834
RefSeq mRNA: 6 — MANE Select: NM_001291529
NM_001291527, NM_001291528, NM_001291529, NM_001291530, NM_001385219, NM_001385220
CCDS: CCDS76035
Canonical transcript exons
ENST00000682849 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003087121 | 135881065 | 135881315 |
| ENSE00003090066 | 135883008 | 135883256 |
| ENSE00003188844 | 135882536 | 135882629 |
| ENSE00003753141 | 135885176 | 135885350 |
| ENSE00003916541 | 135893345 | 135893444 |
Expression profiles
Bgee: expression breadth broad, 56 present calls, max score 93.43.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.6507 / max 71.4845, expressed in 80 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 200622 | 0.3595 | 69 |
| 200621 | 0.2912 | 64 |
Top tissues by expression
104 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 93.43 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 89.25 | gold quality |
| right testis | UBERON:0004534 | 73.62 | gold quality |
| testis | UBERON:0000473 | 69.33 | gold quality |
| left testis | UBERON:0004533 | 66.86 | gold quality |
| Ammon’s horn | UBERON:0001954 | 53.57 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 52.69 | gold quality |
| amygdala | UBERON:0001876 | 49.02 | gold quality |
| temporal lobe | UBERON:0001871 | 48.74 | gold quality |
| substantia nigra | UBERON:0002038 | 43.71 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 43.38 | gold quality |
| hypothalamus | UBERON:0001898 | 43.24 | gold quality |
| bone marrow cell | CL:0002092 | 42.42 | gold quality |
| nucleus accumbens | UBERON:0001882 | 41.08 | gold quality |
| caudate nucleus | UBERON:0001873 | 41.02 | gold quality |
| prefrontal cortex | UBERON:0000451 | 40.97 | gold quality |
| cerebral cortex | UBERON:0000956 | 40.79 | gold quality |
| granulocyte | CL:0000094 | 40.76 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 38.45 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 38.00 | gold quality |
| brain | UBERON:0000955 | 37.45 | gold quality |
| frontal cortex | UBERON:0001870 | 37.24 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 36.86 | silver quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| putamen | UBERON:0001874 | 35.58 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 35.55 | silver quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| bone marrow | UBERON:0002371 | 34.94 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-99795 | no | 16.86 |
| E-ANND-3 | no | 0.81 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
28 targeting CT45A10, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-MIR-4673 | 100.00 | 66.64 | 1490 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-4455 | 100.00 | 65.48 | 1587 |
| HSA-MIR-4645-5P | 99.98 | 65.81 | 1284 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-3671 | 99.90 | 73.04 | 3897 |
| HSA-MIR-221-3P | 99.86 | 71.56 | 1329 |
| HSA-MIR-222-3P | 99.86 | 71.35 | 1337 |
| HSA-MIR-3133 | 99.81 | 70.92 | 3506 |
| HSA-MIR-4668-5P | 99.79 | 70.58 | 3782 |
| HSA-MIR-586 | 99.65 | 70.40 | 2051 |
| HSA-MIR-4506 | 99.34 | 67.47 | 526 |
| HSA-MIR-5006-5P | 98.79 | 66.92 | 1246 |
| HSA-MIR-501-5P | 98.77 | 68.88 | 1328 |
| HSA-MIR-4755-3P | 98.77 | 65.59 | 1915 |
| HSA-MIR-5572 | 98.55 | 65.84 | 970 |
| HSA-MIR-4518 | 98.12 | 66.82 | 1030 |
| HSA-MIR-6819-5P | 97.96 | 66.59 | 1071 |
| HSA-MIR-3151-3P | 97.80 | 66.16 | 479 |
| HSA-MIR-6737-5P | 97.75 | 66.54 | 1044 |
| HSA-MIR-1266-5P | 97.71 | 66.92 | 1052 |
| HSA-MIR-6812-5P | 97.56 | 65.39 | 1059 |
| HSA-MIR-3127-5P | 97.52 | 65.24 | 786 |
| HSA-MIR-937-5P | 97.43 | 68.39 | 667 |
| HSA-MIR-8081 | 96.42 | 67.75 | 738 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Ct45a | ENSMUSG00000064016 |
| rattus_norvegicus | Ct45a9 | ENSRNOG00000048059 |
| drosophila_melanogaster | IntS6 | FBGN0261383 |
| caenorhabditis_elegans | WBGENE00000994 |
Paralogs (11): INTS6 (ENSG00000102786), INTS6L (ENSG00000165359), SAGE1 (ENSG00000181433), CT45A5 (ENSG00000228836), CT45A1 (ENSG00000268940), CT45A3 (ENSG00000269096), CT45A9 (ENSG00000270946), CT45A2 (ENSG00000271449), CT45A7 (ENSG00000273696), CT45A8 (ENSG00000278085), CT45A6 (ENSG00000278289)
Protein
Protein identifiers
Cancer/testis antigen family 45 member A10 — P0DMU9 (reviewed: P0DMU9)
Alternative names: Cancer/testis antigen 45A10
All UniProt accessions (1): P0DMU9
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Nucleus.
Similarity. Belongs to the CT45 family.
RefSeq proteins (6): NP_001278456, NP_001278457, NP_001278458, NP_001278459, NP_001372148, NP_001372149 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029307 | INT_SG_DDX_CT_C | Domain |
| IPR051113 | Integrator_subunit6 | Family |
Pfam: PF15300
UniProt features (1 total): chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0DMU9-F1 | 70.51 | 0.31 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 7 (showing top):
chrXq26, CHAMP1_TARGET_GENES, MIR450A_1_3P, MIR501_5P, CC2D1A_TARGET_GENES, HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_1_CELL, HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_2_CELL
GO Biological Process (0):
GO Molecular Function (2): identical protein binding (GO:0042802), protein binding (GO:0005515)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein binding | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
272 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CT45A10 | DEFB123 | Q8N688 | 506 |
| CT45A10 | CSAG1 | Q6PB30 | 447 |
| CT45A10 | CLPSL1 | A2RUU4 | 412 |
| CT45A10 | MAGEA10 | P43363 | 404 |
| CT45A10 | GAGE12B | A1L429 | 398 |
| CT45A10 | NANOGNB | Q7Z5D8 | 392 |
| CT45A10 | RFPL4B | Q6ZWI9 | 392 |
| CT45A10 | ZNF525 | Q8N782 | 371 |
| CT45A10 | CT45A3 | P0DMU6 | 353 |
| CT45A10 | MAGEB2 | O15479 | 350 |
| CT45A10 | GLB1L2 | Q8IW92 | 348 |
| CT45A10 | PNLIPRP3 | Q17RR3 | 325 |
| CT45A10 | VCX3B | Q9H321 | 325 |
| CT45A10 | FAM180B | Q6P0A1 | 324 |
| CT45A10 | PNMA5 | Q96PV4 | 321 |
IntAct
19 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CT45A10 | SDCBP2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SDCBP | CT45A10 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CT45A10 | CT45A1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CT45A10 | CT45A10 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CT45A10 | DVL3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CT45A10 | SDCBP2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CT45A10 | DVL3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CT45A10 | CT45A1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CT45A10 | SDCBP | psi-mi:“MI:0915”(physical association) | 0.000 |
| CT45A10 | CT45A10 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SDCBP | CT45A10 | psi-mi:“MI:0915”(physical association) | 0.000 |
ESM2 similar proteins: A0FKI7, A2YX04, A5WUN7, A5WV69, A7J1T2, C5DZR8, E9Q555, F4J6F6, O43310, O48767, P0DMS1, P0DMU7, P0DMU8, P0DMU9, P0DMV0, P0DMV1, P0DMV2, Q0V9S3, Q12912, Q14693, Q1LXZ9, Q2NKQ1, Q2PFD7, Q3TEL6, Q502L1, Q5DJT8, Q5R7V3, Q5T8D3, Q5XG73, Q621Z7, Q640U0, Q641E3, Q6IRN6, Q6Z8M8, Q700C2, Q758T8, Q80Y56, Q811D2, Q8AV28, Q8BLN6
Diamond homologs: A6NJ88, P0DMU7, P0DMU8, P0DMU9, P0DMV0, P0DMV1, P0DMV2, Q2TAF4, Q5DJT8, Q5HYN5, Q5JSJ4, Q5U4W6, Q6PCM2, Q7SYD9, Q8BND4, Q8NHU0, Q9NXZ1, Q9UL03, Q54Z23, Q9W485
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
270 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:135883006:A:AC | donor_gain | 1.0000 |
| X:135883007:C:CA | donor_gain | 1.0000 |
| X:135883007:CT:C | donor_gain | 1.0000 |
| X:135883007:CTT:C | donor_gain | 1.0000 |
| X:135882998:CA:C | donor_gain | 0.9900 |
| X:135882998:CACTA:C | donor_gain | 0.9900 |
| X:135883004:TTACT:T | donor_loss | 0.9900 |
| X:135883006:A:C | donor_loss | 0.9900 |
| X:135883006:ACTT:A | donor_gain | 0.9900 |
| X:135883007:C:CC | donor_gain | 0.9900 |
| X:135883007:CTTC:C | donor_gain | 0.9900 |
| X:135883007:CTTCG:C | donor_gain | 0.9900 |
| X:135883002:ACT:A | donor_loss | 0.9800 |
| X:135883040:TG:T | donor_gain | 0.9800 |
| X:135883093:T:TA | donor_gain | 0.9800 |
| X:135883001:TACTT:T | donor_loss | 0.9700 |
| X:135883002:A:AC | donor_gain | 0.9700 |
| X:135883003:C:CC | donor_gain | 0.9700 |
| X:135883003:CTTA:C | donor_gain | 0.9700 |
| X:135883005:TAC:T | donor_loss | 0.9500 |
| X:135889276:G:GG | donor_gain | 0.9300 |
| X:135890437:G:GT | donor_gain | 0.9300 |
| X:135882999:ACTAC:A | donor_loss | 0.9200 |
| X:135882993:T:TA | donor_gain | 0.9000 |
| X:135889374:G:T | donor_gain | 0.9000 |
| X:135883009:T:TA | donor_gain | 0.8900 |
| X:135883002:AC:A | donor_gain | 0.8800 |
| X:135883356:T:A | acceptor_gain | 0.8800 |
| X:135882999:A:C | donor_gain | 0.8700 |
| X:135883035:C:CT | donor_gain | 0.8700 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000302091 (X:135892862 C>T), RS1001478751 (X:135892319 C>A), RS1001845807 (X:135892059 G>A), RS1002444008 (X:135893572 C>G), RS1007929067 (X:135890657 A>C), RS1008973105 (X:135893140 T>C), RS1009355060 (X:135892865 G>A,T), RS1010058538 (X:135892407 G>A,C,T), RS1010278238 (X:135892141 C>G), RS1013297055 (X:135889920 C>T), RS1015263915 (X:135890702 T>C), RS1015295202 (X:135891238 A>G), RS1018969993 (X:135893141 G>A), RS1020072444 (X:135892438 C>T), RS1020291415 (X:135892142 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
1 total (human), top 1 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Tretinoin | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.